Aprea Therapeutics, Inc.
41 SEC EDGAR filings indexed (CIK 0001781983) across 11 form types.
Filing profile
Aprea Therapeutics, Inc. (APRE) has 41 SEC filings indexed on SecFilingDex, across 11 form types filed over roughly 2 years, from March 26, 2024 to August 12, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 27 of these filings were disclosed in the twelve months to August 12, 2026.
Disclosure mix
- 88-KMaterial event · event-driven
- 810-QQuarterly report · quarterly
- 8Form 4Insider transaction · within 2 business days of transaction
- 4424B3Updated prospectus · event-driven
- 3DEF 14AProxy statement · annual (pre-meeting)
- 3DEFA14ASEC filing
- 310-KAnnual report · annual
- 1PRE 14ASEC filing
- 1424B5Prospectus supplement · event-driven
- 1SC 13G5%+ passive stake · event-driven
- 1Form 3Initial insider ownership · within 10 days of becoming an insider
Profile derived from 41 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
- 8-KMaterial event · period of report Aug 12, 2026Filed · 0001104659-26-094542
- 10-QQuarterly report · period of report Jun 30, 2026Filed · 0001104659-26-094544
- 8-KMaterial event · period of report Jul 23, 2026Filed · 0001104659-26-086254
- 8-KMaterial event · period of report Jun 16, 2026Filed · 0001104659-26-075151
- Form 4Insider transaction · period of report Jun 16, 2026Filed · 0001104659-26-075278
- Form 4Insider transaction · period of report Jun 16, 2026Filed · 0001104659-26-075279
- Form 4Insider transaction · period of report Jun 16, 2026Filed · 0001104659-26-075280
- Form 4Insider transaction · period of report Jun 16, 2026Filed · 0001104659-26-075281
- Form 4Insider transaction · period of report Jun 16, 2026Filed · 0001104659-26-075282
- Form 4Insider transaction · period of report Jun 16, 2026Filed · 0001104659-26-075283
- Form 4Insider transaction · period of report Jun 16, 2026Filed · 0001104659-26-075284
- Form 4Insider transaction · period of report Jun 16, 2026Filed · 0001104659-26-075286
- 8-KMaterial event · period of report May 13, 2026Filed · 0001104659-26-059734
- 10-QQuarterly report · period of report Mar 31, 2026Filed · 0001104659-26-059743
- DEF 14AProxy statementFiled · 0001104659-26-052044
- DEFA14ASEC filingFiled · 0001104659-26-052049
- 424B3Updated prospectusFiled · 0001104659-26-051739
- PRE 14ASEC filing · period of report Jun 16, 2026Filed · 0001104659-26-045158
- 8-KMaterial event · period of report Apr 1, 2026Filed · 0001104659-26-038258
- 8-KMaterial event · period of report Mar 30, 2026Filed · 0001104659-26-036821
- 424B3Updated prospectusFiled · 0001104659-26-032181
- 8-KMaterial event · period of report Mar 16, 2026Filed · 0001104659-26-028046
- 10-KAnnual report · period of report Dec 31, 2025Filed · 0001104659-26-028068
- 8-KMaterial event · period of report Feb 18, 2026Filed · 0001104659-26-016797
- 424B3Updated prospectusFiled · 0001104659-25-124943
- 10-QQuarterly report · period of report Sep 30, 2025Filed · 0001104659-25-109867
- 10-QQuarterly report · period of report Jun 30, 2025Filed · 0001558370-25-011152
- 10-QQuarterly report · period of report Mar 31, 2025Filed · 0001558370-25-007667
- DEF 14AProxy statement · period of report Jun 5, 2025Filed · 0001558370-25-005141
- DEFA14ASEC filingFiled · 0001558370-25-005145
- 10-KAnnual report · period of report Dec 31, 2024Filed · 0001558370-25-003588
- 424B5Prospectus supplementFiled · 0001104659-24-115902
- 10-QQuarterly report · period of report Sep 30, 2024Filed · 0001558370-24-014767
- SC 13G5%+ passive stakeFiled · 0000935836-24-000631
- 10-QQuarterly report · period of report Jun 30, 2024Filed · 0001558370-24-011806
- 10-QQuarterly report · period of report Mar 31, 2024Filed · 0001558370-24-008069
- Form 3Initial insider ownership · period of report May 1, 2024Filed · 0001104659-24-056395
- 424B3Updated prospectusFiled · 0001104659-24-054473
- DEF 14AProxy statement · period of report Jun 20, 2024Filed · 0001558370-24-005678
- DEFA14ASEC filingFiled · 0001558370-24-005683
- 10-KAnnual report · period of report Dec 31, 2023Filed · 0001558370-24-003886
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.